Subscribe
Logo small
Search
banner

AOTMiT: Transparency Council on menopause, target import and reimbursement in off-label indications, among others

MedExpress Team

medexpress.pl

Published Sept. 2, 2024 08:57

AOTMiT: Transparency Council on menopause, target import and reimbursement in off-label indications, among others - Header image
Źródło: AOTMiT
Today another meeting of the AOTMiT Transparency Council.

Agenda:

  • 1. veoza (fezolinetantum) for the indication: treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause

Decision-making problem: preparing a position on target imports (Article 39)

2.Milupa Basic F in indications:

  • CACT deficit,
  • VLCAD deficit,
  • Lymphadenopathy (including conditions after cardiac surgery),
  • abetalipoproteinemia,
  • Lipid metabolism disorders (hypercholesterolemia and hypertriglyceridemia), lipoprotein lipase deficiency.
  • ...

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also